FdaApplication
ANDA 204104
Identifiers
- fda_app_no: ANDA204104
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2023-04-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | 25MG/VIAL | POWDER;INTRAVENOUS |
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | 100MG/VIAL | POWDER;INTRAVENOUS |
2 products